Author

S. E. Andersen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:bacteria (other)· 2 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

B. A. Duerkop· 2 shared A. Chatterjee· 1 shared B. S. Imai· 1 shared B. Steiert· 1 shared C. A. Elwell· 1 shared C. N. Johnson· 1 shared C. Suetterlin· 1 shared E. K. Sheriff· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. A. Duerkop

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Enterococcal quorum-controlled protease alters phage infection

E. K. Sheriff, F. Salvato, S. E. Andersen, A. Chatterjee, M. Kleiner, B. A. Duerkop

The paper investigates how Enterococcus faecalis protease GelE affects phage infection, finding that its reduction increases phage susceptibility and alters biofilm formation.

bioRxiv · May 10, 2024Microbiology

The Chlamydia trachomatis secreted effector CebN targets nucleoporins and Rae1 to antagonize STAT1 nuclear import

B. Steiert, C. A. Elwell, X. Tijerina, M. A. Elliott, Y. Delgado, J. NI, R. Faris, P. Smith, S. E. Andersen, P. N. McCaslin, J. K.-Y. Kevil-Yeager, Q. Eldridge, B. S. Imai, J. V. Arrington, P. M. Yau, , M. M. Weber

This study identifies CebN, a Chlamydia trachomatis effector that targets nucleoporins and Rae1 to disrupt STAT1 nuclear import, aiding bacterial survival.

bioRxiv · Apr 25, 2024 · PreprintMicrobiology

An enterococcal phage protein broadly inhibits type IV restriction enzymes involved in antiphage defense

N. P. Bullen, C. N. Johnson, S. E. Andersen, G. Arya, S. R. Marotta, Y.-J. Lee, P. Weigele, J. C. Whitney, B. A. Duerkop

The paper identifies a phage protein that inhibits type IV restriction enzymes in drug-resistant enterococci, revealing how phages evolve to overcome bacterial defense mechanisms.

bioRxiv · Nov 16, 2023Microbiology